These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


210 related items for PubMed ID: 8624818

  • 1. CD40 ligand is required for protective cell-mediated immunity to Leishmania major.
    Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR.
    Immunity; 1996 Mar; 4(3):283-9. PubMed ID: 8624818
    [Abstract] [Full Text] [Related]

  • 2. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity.
    Kamanaka M, Yu P, Yasui T, Yoshida K, Kawabe T, Horii T, Kishimoto T, Kikutani H.
    Immunity; 1996 Mar; 4(3):275-81. PubMed ID: 8624817
    [Abstract] [Full Text] [Related]

  • 3. IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process.
    Marovich MA, McDowell MA, Thomas EK, Nutman TB.
    J Immunol; 2000 Jun 01; 164(11):5858-65. PubMed ID: 10820265
    [Abstract] [Full Text] [Related]

  • 4. Interaction of Macrophage Antigen 1 and CD40 Ligand Leads to IL-12 Production and Resistance in CD40-Deficient Mice Infected with Leishmania major.
    Okwor I, Jia P, Uzonna JE.
    J Immunol; 2015 Oct 01; 195(7):3218-26. PubMed ID: 26304989
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses.
    Kelsall BL, Stüber E, Neurath M, Strober W.
    Ann N Y Acad Sci; 1996 Oct 31; 795():116-26. PubMed ID: 8958922
    [Abstract] [Full Text] [Related]

  • 6. TRANCE-RANK costimulation is required for IL-12 production and the initiation of a Th1-type response to Leishmania major infection in CD40L-deficient mice.
    Padigel UM, Kim N, Choi Y, Farrell JP.
    J Immunol; 2003 Nov 15; 171(10):5437-41. PubMed ID: 14607948
    [Abstract] [Full Text] [Related]

  • 7. The development of a Th1-type response and resistance to Leishmania major infection in the absence of CD40-CD40L costimulation.
    Padigel UM, Perrin PJ, Farrell JP.
    J Immunol; 2001 Nov 15; 167(10):5874-9. PubMed ID: 11698463
    [Abstract] [Full Text] [Related]

  • 8. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb.
    Ferlin WG, von der Weid T, Cottrez F, Ferrick DA, Coffman RL, Howard MC.
    Eur J Immunol; 1998 Feb 15; 28(2):525-31. PubMed ID: 9521062
    [Abstract] [Full Text] [Related]

  • 9. CD40-CD40 ligand costimulation is not required for initiation and maintenance of a Th1-type response to Leishmania major infection.
    Padigel UM, Farrell JP.
    Infect Immun; 2003 Mar 15; 71(3):1389-95. PubMed ID: 12595456
    [Abstract] [Full Text] [Related]

  • 10. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection.
    Soong L, Xu JC, Grewal IS, Kima P, Sun J, Longley BJ, Ruddle NH, McMahon-Pratt D, Flavell RA.
    Immunity; 1996 Mar 15; 4(3):263-73. PubMed ID: 8624816
    [Abstract] [Full Text] [Related]

  • 11. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages.
    Kennedy MK, Picha KS, Fanslow WC, Grabstein KH, Alderson MR, Clifford KN, Chin WA, Mohler KM.
    Eur J Immunol; 1996 Feb 15; 26(2):370-8. PubMed ID: 8617306
    [Abstract] [Full Text] [Related]

  • 12. Pathways leading to interleukin-12 production and protective immunity in cutaneous leishmaniasis.
    Okwor I, Uzonna JE.
    Cell Immunol; 2016 Nov 15; 309():32-36. PubMed ID: 27394077
    [Abstract] [Full Text] [Related]

  • 13. Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity.
    Heinzel FP, Rerko RM, Hujer AM.
    Cell Immunol; 1998 Mar 15; 184(2):129-42. PubMed ID: 9630839
    [Abstract] [Full Text] [Related]

  • 14. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
    von Stebut E, Belkaid Y, Nguyen BV, Cushing M, Sacks DL, Udey MC.
    Eur J Immunol; 2000 Dec 15; 30(12):3498-506. PubMed ID: 11093169
    [Abstract] [Full Text] [Related]

  • 15. Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC.
    Ramírez-Pineda JR, Fröhlich A, Berberich C, Moll H.
    J Immunol; 2004 May 15; 172(10):6281-9. PubMed ID: 15128817
    [Abstract] [Full Text] [Related]

  • 16. IL-12 is required to maintain a Th1 response during Leishmania major infection.
    Park AY, Hondowicz BD, Scott P.
    J Immunol; 2000 Jul 15; 165(2):896-902. PubMed ID: 10878364
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of CD40-induced N-Ras activation reduces leishmania major infection.
    Chakraborty S, Srivastava A, Jha MK, Nair A, Pandey SP, Srivastava N, Kumari S, Singh S, Krishnasastry MV, Saha B.
    J Immunol; 2015 Apr 15; 194(8):3852-60. PubMed ID: 25786685
    [Abstract] [Full Text] [Related]

  • 18. A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy.
    Yamauchi PS, Bleharski JR, Uyemura K, Kim J, Sieling PA, Miller A, Brightbill H, Schlienger K, Rea TH, Modlin RL.
    J Immunol; 2000 Aug 01; 165(3):1506-12. PubMed ID: 10903757
    [Abstract] [Full Text] [Related]

  • 19. NF-kappa B1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major.
    Artis D, Speirs K, Joyce K, Goldschmidt M, Caamaño J, Hunter CA, Scott P.
    J Immunol; 2003 Feb 15; 170(4):1995-2003. PubMed ID: 12574369
    [Abstract] [Full Text] [Related]

  • 20. IL-9 is a susceptibility factor in Leishmania major infection by promoting detrimental Th2/type 2 responses.
    Arendse B, Van Snick J, Brombacher F.
    J Immunol; 2005 Feb 15; 174(4):2205-11. PubMed ID: 15699153
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.